Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Daniel

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
BMC Medical Research Methodology|November 28, 2012
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsSebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, et al.
Transfusion|March 28, 2012
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010Gregory W Daniel, Mikhail Menis, Gayathri Sridhar, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
Design considerations, architecture, and use of the Mini-Sentinel distributed data systemLesley H Curtis, Mark G Weiner, Denise M Boudreau, et al.
Drug Safety|April 12, 2012
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examplesPeter M Wahl, Joshua J Gagne, Thomas E Wasser, et al.
Pharmacoepidemiology and Drug Safety|June 30, 2012
Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel programSarah L Cutrona, Sengwee Toh, Aarthi Iyer, et al.
Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products, Mike Baldziki, Jeff Brown, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
BMC Medical Research Methodology|November 28, 2012
Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatmentsSebastian Schneeweiss, Jeremy A Rassen, Robert J Glynn, et al.
Transfusion|March 28, 2012
Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010Gregory W Daniel, Mikhail Menis, Gayathri Sridhar, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
Design considerations, architecture, and use of the Mini-Sentinel distributed data systemLesley H Curtis, Mark G Weiner, Denise M Boudreau, et al.
Drug Safety|April 12, 2012
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examplesPeter M Wahl, Joshua J Gagne, Thomas E Wasser, et al.
Pharmacoepidemiology and Drug Safety|June 30, 2012
Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel programSarah L Cutrona, Sengwee Toh, Aarthi Iyer, et al.
Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products, Mike Baldziki, Jeff Brown, et al.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
Pageof 3